Literature DB >> 11278685

Physical interaction with Yes-associated protein enhances p73 transcriptional activity.

S Strano1, E Munarriz, M Rossi, L Castagnoli, Y Shaul, A Sacchi, M Oren, M Sudol, G Cesareni, G Blandino.   

Abstract

Specific protein-protein interactions are involved in a large number of cellular processes and are mainly mediated by structurally and functionally defined domains. Here we report that the nuclear phosphoprotein p73 can engage in a physical association with the Yes-associated protein (YAP). This association occurs under physiological conditions as shown by reciprocal co-immunoprecipitation of complexes from lysates of P19 cells. The WW domain of YAP and the PPPPY motif of p73 are directly involved in the association. Furthermore, as required for ligands to group I WW domains, the terminal tyrosine (Y) of the PPPPY motif of p73 was shown to be essential for the association with YAP. Unlike p73alpha, p73beta, and p63alpha, which bind to YAP, the endogenous as well as exogenously expressed wild-type p53 (wt-p53) and the p73gamma isoform do not interact with YAP. Indeed, we documented that YAP interacts only with those members of the p53 family that have a well conserved PPXY motif, a target sequence for WW domains. Overexpression of YAP causes an increase of p73alpha transcriptional activity. Differential interaction of YAP with members of the p53 family may provide a molecular explanation for their functional divergence in signaling.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278685     DOI: 10.1074/jbc.M010484200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  158 in total

1.  c-Abl antagonizes the YAP oncogenic function.

Authors:  R Keshet; J Adler; I Ricardo Lax; M Shanzer; Z Porat; N Reuven; Y Shaul
Journal:  Cell Death Differ       Date:  2014-10-31       Impact factor: 15.828

2.  Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains.

Authors:  Pamela Ghioni; Fabrizio Bolognese; Pascal H G Duijf; Hans Van Bokhoven; Roberto Mantovani; Luisa Guerrini
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

3.  Overexpression of YAP1 induces immortalization of normal human keratinocytes by blocking clonal evolution.

Authors:  Irene D'Addario; Claudia Abbruzzese; Marco Lo Iacono; Massimo Teson; Osvaldo Golisano; Virginia Barone
Journal:  Histochem Cell Biol       Date:  2010-07-31       Impact factor: 4.304

Review 4.  Hippo signaling: growth control and beyond.

Authors:  Georg Halder; Randy L Johnson
Journal:  Development       Date:  2011-01       Impact factor: 6.868

5.  Hippo signaling at a glance.

Authors:  Bin Zhao; Li Li; Kun-Liang Guan
Journal:  J Cell Sci       Date:  2010-12-01       Impact factor: 5.285

6.  Hippo signaling is required for Notch-dependent smooth muscle differentiation of neural crest.

Authors:  Lauren J Manderfield; Haig Aghajanian; Kurt A Engleka; Lillian Y Lim; Feiyan Liu; Rajan Jain; Li Li; Eric N Olson; Jonathan A Epstein
Journal:  Development       Date:  2015-08-07       Impact factor: 6.868

Review 7.  Gone Caving: Roles of the Transcriptional Regulators YAP and TAZ in Skeletal Development.

Authors:  Christopher D Kegelman; Joseph M Collins; Madhura P Nijsure; Emily A Eastburn; Joel D Boerckel
Journal:  Curr Osteoporos Rep       Date:  2020-10       Impact factor: 5.096

Review 8.  The p53 family and programmed cell death.

Authors:  E C Pietsch; S M Sykes; S B McMahon; M E Murphy
Journal:  Oncogene       Date:  2008-10-27       Impact factor: 9.867

9.  EGF Receptor-Dependent YAP Activation Is Important for Renal Recovery from AKI.

Authors:  Jianchun Chen; Huaizhou You; Yan Li; You Xu; Qian He; Raymond C Harris
Journal:  J Am Soc Nephrol       Date:  2018-08-02       Impact factor: 10.121

Review 10.  The Hippo-YAP pathway: new connections between regulation of organ size and cancer.

Authors:  Bin Zhao; Qun-Ying Lei; Kun-Liang Guan
Journal:  Curr Opin Cell Biol       Date:  2008-11-18       Impact factor: 8.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.